Perfeziona i miei risultati

Document type

Institution

Collection spécifique

Lingua

Autore

Domaine

Parola chiave

Perfeziona i miei risultati

Document type

Institution

Collection spécifique

Lingua

Autore

Domaine

Parola chiave

Prolonged complete remission of metastatic HER2-positive breast cancer after continuous trastuzumab treatment: a case report and review of the literature

Morphological and molecular characteristics of HER2 amplified urothelial bladder cancer

Co-amplification of the HER2 gene and chromosome 17 centromere: a potential diagnostic pitfall in HER2 testing in breast cancer

PTP1B expression is an independent positive prognostic factor in human breast cancer

The Role of Overexpressed HER2 in Transformation

Combined cetuximab and trastuzumab are superior to gemcitabine in the treatment of human pancreatic carcinoma xenografts

Phase I trial combining temozolomide plus lapatinib for the treatment of brain metastases in patients with HER2-positive metastatic breast cancer: the LAPTEM trial

Perfeziona i miei risultati

Document type

Institution

Collection spécifique

Lingua

Autore

Domaine

Parola chiave

Prolonged complete remission of metastatic HER2-positive breast cancer after continuous trastuzumab treatment: a case report and review of the literature

Ihnenfeld Arciénega, Isabel ; Imesch, Patrick ; Fink, Daniel ; Dedes, Konstantin

In: Targeted Oncology, 2015, vol. 10, no. 2, p. 297-301

Morphological and molecular characteristics of HER2 amplified urothelial bladder cancer

Tschui, J. ; Vassella, E. ; Bandi, N. ; Baumgartner, U. ; Genitsch, V. ; Rotzer, D. ; Seiler, R. ; Thalmann, G. ; Fleischmann, A.

In: Virchows Archiv, 2015, vol. 466, no. 6, p. 703-710

Co-amplification of the HER2 gene and chromosome 17 centromere: a potential diagnostic pitfall in HER2 testing in breast cancer

Varga, Zsuzsanna ; Tubbs, Raymond ; Wang, Zhen ; Sun, Yang ; Noske, Aurelia ; Kradolfer, Doris ; Bosshard, Giovanna ; Jochum, Wolfram ; Moch, Holger ; Öhlschlegel, Christian

In: Breast Cancer Research and Treatment, 2012, vol. 132, no. 3, p. 925-935

PTP1B expression is an independent positive prognostic factor in human breast cancer

Soysal, S. ; Obermann, E. ; Gao, F. ; Oertli, D. ; Gillanders, W. ; Viehl, C. ; Muenst, S.

In: Breast Cancer Research and Treatment, 2013, vol. 137, no. 2, p. 637-644

The Role of Overexpressed HER2 in Transformation

Neve, R. M. ; Lane, H. A. ; Hynes, N. E.

In: Annals of Oncology, 2001, vol. 12, p. S9-S13

Combined cetuximab and trastuzumab are superior to gemcitabine in the treatment of human pancreatic carcinoma xenografts

Larbouret, C. ; Robert, B. ; Bascoul-Mollevi, C. ; Penault-Llorca, F. ; Ho-Pun-Cheung, A. ; Morisseau, S. ; Navarro-Teulon, I. ; Mach, J.-P ; Pèlegrin, A. ; Azria, D.

In: Annals of Oncology, 2009, vol. 21, no. 1, p. 98-103

Phase I trial combining temozolomide plus lapatinib for the treatment of brain metastases in patients with HER2-positive metastatic breast cancer: the LAPTEM trial

de Azambuja, E. ; Zardavas, D. ; Lemort, M. ; Rossari, J. ; Moulin, C. ; Buttice, A. ; D'Hondt, V. ; Lebrun, F. ; Lalami, Y. ; Cardoso, F. ; Sotiriou, C. ; Gil, T. ; Devriendt, D. ; Paesmans, M. ; Piccart-Gebhart, M. ; Awada, A.

In: Annals of Oncology, 2013, vol. 24, no. 12, p. 2985-2989